BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 25559012)

  • 1. Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark.
    Jabbari R; Engstrøm T; Glinge C; Risgaard B; Jabbari J; Winkel BG; Terkelsen CJ; Tilsted HH; Jensen LO; Hougaard M; Chiuve SE; Pedersen F; Svendsen JH; Haunsø S; Albert CM; Tfelt-Hansen J
    J Am Heart Assoc; 2015 Jan; 4(1):e001399. PubMed ID: 25559012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated With and Outcomes After Ventricular Fibrillation Before and During Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction.
    Jabbari R; Risgaard B; Fosbøl EL; Scheike T; Philbert BT; Winkel BG; Albert CM; Glinge C; Ahtarovski KA; Haunsø S; Køber L; Jørgensen E; Pedersen F; Tfelt-Hansen J; Engstrøm T
    Am J Cardiol; 2015 Sep; 116(5):678-85. PubMed ID: 26150175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in clinical characteristics in patients with first ST-segment elevation myocardial infarction and ventricular fibrillation according to sex.
    Jabbari R; Glinge C; Risgaard B; Lynge TH; Winkel BG; Haunsø S; Albert CM; Engstrøm T; Tfelt-Hansen J
    J Interv Card Electrophysiol; 2017 Oct; 50(1):133-140. PubMed ID: 28939955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial).
    Mehta RH; Yu J; Piccini JP; Tcheng JE; Farkouh ME; Reiffel J; Fahy M; Mehran R; Stone GW
    Am J Cardiol; 2012 Mar; 109(6):805-12. PubMed ID: 22196782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular fibrillation and sudden cardiac death during myocardial infarction.
    Jabbari R
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation is an independent risk factor for ventricular fibrillation: a large-scale population-based case-control study.
    Bardai A; Blom MT; van Hoeijen DA; van Deutekom HW; Brouwer HJ; Tan HL
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1033-9. PubMed ID: 25236735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.
    Mehta RH; Starr AZ; Lopes RD; Hochman JS; Widimsky P; Pieper KS; Armstrong PW; Granger CB;
    JAMA; 2009 May; 301(17):1779-89. PubMed ID: 19417195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and time frame of life-threatening arrhythmias in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Cricri P; Trachsel LD; Müller P; Wäckerlin A; Reinhart WH; Bonetti PO
    Swiss Med Wkly; 2012; 142():w13604. PubMed ID: 22685036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium Disturbances and Risk of Ventricular Fibrillation Among Patients With ST-Segment-Elevation Myocardial Infarction.
    Ravn Jacobsen M; Jabbari R; Glinge C; Kjær Stampe N; Butt JH; Blanche P; Lønborg J; Wendelboe Nielsen O; Køber L; Torp-Pedersen C; Pedersen F; Tfelt-Hansen J; Engstrøm T
    J Am Heart Assoc; 2020 Feb; 9(4):e014160. PubMed ID: 32067598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of common genetic variants related to atrial fibrillation and the risk of ventricular fibrillation in the setting of first ST-elevation myocardial infarction.
    Jabbari R; Jabbari J; Glinge C; Risgaard B; Sattler S; Winkel BG; Terkelsen CJ; Tilsted HH; Jensen LO; Hougaard M; Haunsø S; Engstrøm T; Albert CM; Tfelt-Hansen J
    BMC Med Genet; 2017 Nov; 18(1):138. PubMed ID: 29162046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
    de Jong JS; Marsman RF; Henriques JP; Koch KT; de Winter RJ; Tanck MW; Wilde AA; Dekker LR
    Am Heart J; 2009 Sep; 158(3):467-72. PubMed ID: 19699872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Common Variant in SCN5A and the Risk of Ventricular Fibrillation Caused by First ST-Segment Elevation Myocardial Infarction.
    Jabbari R; Glinge C; Jabbari J; Risgaard B; Winkel BG; Terkelsen CJ; Tilsted HH; Jensen LO; Hougaard M; Haunsø S; Engstrøm T; Albert CM; Tfelt-Hansen J
    PLoS One; 2017; 12(1):e0170193. PubMed ID: 28085969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of ventricular fibrillation at reperfusion in patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Demidova MM; Carlson J; Erlinge D; Platonov PG
    Am J Cardiol; 2015 Feb; 115(4):417-22. PubMed ID: 25549882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of invasive treatment and the occurrence of cardiac rupture in acute ST-elevation myocardial infarction.
    Ptaszyńska-Kopczyńska K; Sobolewska D; Kożuch M; Dobrzycki S; Sobkowicz B; Hirnle T; Musiał WJ; Kamiński KA
    Kardiol Pol; 2011; 69(8):795-800. PubMed ID: 21850621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients.
    Dekker LR; Bezzina CR; Henriques JP; Tanck MW; Koch KT; Alings MW; Arnold AE; de Boer MJ; Gorgels AP; Michels HR; Verkerk A; Verheugt FW; Zijlstra F; Wilde AA
    Circulation; 2006 Sep; 114(11):1140-5. PubMed ID: 16940195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes.
    Mehta RH; Harjai KJ; Grines L; Stone GW; Boura J; Cox D; O'Neill W; Grines CL;
    J Am Coll Cardiol; 2004 May; 43(10):1765-72. PubMed ID: 15145097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of out-of-hospital cardiac arrest due to ventricular fibrillation in patients with ST-elevation myocardial infarction admitted for primary percutaneous coronary intervention: Impact of ventricular fibrillation in STEMI patients.
    Demirel F; Rasoul S; Elvan A; Ottervanger JP; Dambrink JH; Gosselink AT; Hoorntje JC; Ramdat Misier AR; van 't Hof AW
    Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):16-23. PubMed ID: 25114328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Damman P; Kuijt WJ; Woudstra P; Haeck JD; Koch KT; Gu YL; van Straalen JP; Fischer J; Tijssen JG; Krucoff MW; de Winter RJ
    Am Heart J; 2012 May; 163(5):783-9. PubMed ID: 22607855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricemia is associated with an increased prevalence of ventricular tachycardia and fibrillation in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention.
    Hu X; Fu S; Wang S
    BMC Cardiovasc Disord; 2022 Apr; 22(1):199. PubMed ID: 35473480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.